Taro Iguchi

2.5k total citations · 2 hit papers
69 papers, 1.6k citations indexed

About

Taro Iguchi is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Cancer Research. According to data from OpenAlex, Taro Iguchi has authored 69 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Pulmonary and Respiratory Medicine, 23 papers in Radiology, Nuclear Medicine and Imaging and 19 papers in Cancer Research. Recurrent topics in Taro Iguchi's work include Prostate Cancer Treatment and Research (37 papers), Radiopharmaceutical Chemistry and Applications (22 papers) and Cancer, Lipids, and Metabolism (14 papers). Taro Iguchi is often cited by papers focused on Prostate Cancer Treatment and Research (37 papers), Radiopharmaceutical Chemistry and Applications (22 papers) and Cancer, Lipids, and Metabolism (14 papers). Taro Iguchi collaborates with scholars based in Japan, United States and Germany. Taro Iguchi's co-authors include Arnulf Stenzl, Andrew J. Armstrong, B. Yа. Alekseev, Russell Z. Szmulewitz, Brad Rosbrook, Neal D. Shore, Arun Azad, Arnauld Villers, Antonio Alcaraz and Daniel P. Petrylak and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Journal of Urology.

In The Last Decade

Taro Iguchi

66 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer

2019 686 citations Andrew J. Armstrong, Russell Z. Szmulewitz et al. profile →
Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer

2022 169 citations Andrew J. Armstrong, Arun Azad et al. profile →

Peers

Countries citing papers authored by Taro Iguchi

Since Specialization

Citations

This map shows the geographic impact of Taro Iguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taro Iguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taro Iguchi more than expected).

Fields of papers citing papers by Taro Iguchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taro Iguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taro Iguchi. The network helps show where Taro Iguchi may publish in the future.

Co-authorship network of co-authors of Taro Iguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Taro Iguchi. A scholar is included among the top collaborators of Taro Iguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taro Iguchi. Taro Iguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Efficacy of Enzalutamide plus Androgen Deprivation Therapy in Oligometastatic Hormone-sensitive Prostate Cancer: A Post Hoc Analysis of ARCHES 2023 ·European Urology ·Andrew J. Armstrong, Taro Iguchi, Arun Azad, Arnauld Villers, B. Yа. Alekseev, Daniel P. Petrylak, Russell Z. Szmulewitz, Antonio Alcaraz, Neal D. Shore, Jeffrey M. Holzbeierlein, F. Gómez-Veiga, Brad Rosbrook, Fabian Zohren, Gabriel P. Haas, (unknown), (unknown), Arnulf Stenzl	11
2	Clinical Outcomes of Enzalutamide in Metastatic Hormone-sensitive Prostate Cancer in Patients Aged <75 and ≥75 Years: ARCHES Post Hoc Analysis 2023 ·European Urology Oncology ·F. Gómez-Veiga, Russell Z. Szmulewitz, Jeffrey M. Holzbeierlein, Arun Azad, Taro Iguchi, Arnauld Villers, Antonio Alcaraz, B. Yа. Alekseev, Neal D. Shore, Brad Rosbrook, Fabian Zohren, Jie Ma, Gabriel P. Haas, Arnulf Stenzl, Andrew J. Armstrong	3
3	Effect of Enzalutamide plus Androgen Deprivation Therapy on Health-related Quality of Life in Patients with Metastatic Hormone-sensitive Prostate Cancer: An Analysis of the ARCHES Randomised, Placebo-controlled, Phase 3 Study 2020 ·European Urology ·Arnulf Stenzl, Curtis Dunshee, Ugo De Giorgi, B. Yа. Alekseev, Taro Iguchi, Russell Z. Szmulewitz, Thomas W. Flaig, Bertrand Tombal, Robert Morlock, Cristina Ivanescu, Krishnan Ramaswamy, Fred Saad, Andrew J. Armstrong	33
4	Myeloid-derived suppressor cells are essential partners for immune checkpoint inhibitors in the treatment of cisplatin-resistant bladder cancer 2020 ·Cancer Letters ·(unknown), Minoru Kato, Satoshi Tamada, (unknown), (unknown), Taro Iguchi, Takeshi Yamasaki, Min Gi, Hideki Wanibuchi, Tatsuya Nakatani	50
5	Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: study protocol for a multicenter randomized phase II trial (the OCUU-CRPC study) 2019 ·BMC Cancer ·Taro Iguchi, Satoshi Tamada, Minoru Kato, (unknown), Takeshi Yamasaki, Tatsuya Nakatani	16
6	Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: the OCUU-CRPC study 2019 ·International Journal of Clinical Oncology ·Taro Iguchi, Satoshi Tamada, Minoru Kato, (unknown), Yuichi Machida, (unknown), (unknown), Hiroyuki Iwata, Shinji Yamamoto, (unknown), (unknown), T. Hase, (unknown), (unknown), Takashi Deguchi, (unknown), (unknown), (unknown), Tatsuya Nakatani	12
7	Notch Signaling Enhances Stemness by Regulating Metabolic Pathways Through Modifying p53, NF-κB, and HIF-1α 2018 ·Stem Cells and Development ·Hiroyuki Moriyama, Mariko Moriyama, Toshiyuki Ozawa, Daisuke Tsuruta, Taro Iguchi, Satoshi Tamada, Tatsuya Nakatani, Koichi Nakagawa, Takao Hayakawa	36
8	Treatment outcomes of ureteral stenting for malignant extrinsic ureteral obstruction: a comparison between polymeric and metallic stents 2018 ·Cancer Management and Research ·(unknown), Taro Iguchi, Satoshi Tamada, (unknown), Minoru Kato, Takeshi Yamasaki, Tatsuya Nakatani	16
9	Comparison of efficacy and toxicity of second-line combination chemotherapy regimens in patients with advanced urothelial carcinoma 2018 ·International Journal of Clinical Oncology ·(unknown), Minoru Kato, (unknown), Takeshi Yamasaki, Taro Iguchi, Satoshi Tamada, Katsuyuki Kuratsukuri, Tatsuya Nakatani	4
10	A change from gonadotropin releasing hormone antagonist to gonadotropin releasing hormone agonist therapy does not affect the oncological outcomes in hormone sensitive prostate cancer 2018 ·Basic and Clinical Andrology ·(unknown), Taro Iguchi, Satoshi Tamada, (unknown), (unknown), Minoru Kato, Takeshi Yamasaki, (unknown), Tatsuya Nakatani	7
11	[Bone and Calcium Research Update 2015. Clinical update of urolithiasis--ESWL (extracorporeal shock wave lithotripsy)]. 2015 ·PubMed ·Taro Iguchi, Tatsuya Nakatani	1
12	Association of MnSOD AA Genotype with the Progression of Prostate Cancer 2015 ·PLoS ONE ·Taro Iguchi, Ching Y. Wang, Nicolas Barry Delongchamps, Minoru Kato, Satoshi Tamada, Takeshi Yamasaki, Gustavo de la Roza, Tatsuya Nakatani, Gabriel P. Haas	11
13	A Case of Pulmonary Pleomorphic Carcinoma With Renal Metastasis 2014 ·Urology Case Reports ·(unknown), Taro Iguchi, (unknown), Yuichi Machida, Katsuyuki Kuratsukuri, Hidenori Kawashima, Tatsuya Nakatani	3
14	Hyperintense plaque identified by magnetic resonance imaging relates to intracoronary thrombus as detected by optical coherence tomography in patients with angina pectoris 2012 ·European Heart Journal - Cardiovascular Imaging ·Shoichi Ehara, Tsuyoshi Hasegawa, Satoshi Nakata, Kenji Matsumoto, Satoshi Nishimura, Taro Iguchi, Toru Kataoka, Junichi Yoshikawa, M. Yoshiyama	40
15	Glucose intolerance in renal transplant recipients is associated with increased urinary albumin excretion 2011 ·Transplant Immunology ·Junji Uchida, Tomoaki Iwai, Nobuyuki Kuwabara, Yuichi Machida, Taro Iguchi, Toshihide Naganuma, (unknown), Hidenori Kawashima, Tatsuya Nakatani	9
16	Clinical Outcome of ABO-Incompatible Living Unrelated Donor Kidney Transplantation 2011 ·Urologia Internationalis ·Junji Uchida, Yuichi Machida, Tomoaki Iwai, Nobuyuki Kuwabara, Taro Iguchi, Toshihide Naganuma, (unknown), Hidenori Kawashima, Tatsuya Nakatani	16
17	Low-grade albuminuria reduction with angiotensin II type 1 receptor blocker in renal transplant recipients 2011 ·Journal of Nephrology ·Junji Uchida, Yuichi Machida, Tomoaki Iwai, Taro Iguchi, (unknown), Toshihide Naganuma, (unknown), (unknown), Hidenori Kawashima, Tatsuya Nakatani	14
18	Desensitization Protocol in Highly HLA-Sensitized and ABO-Incompatible High Titer Kidney Transplantation 2010 ·Transplantation Proceedings ·Junji Uchida, Yuichi Machida, Tomoaki Iwai, Toshihide Naganuma, K. Kitamoto, Taro Iguchi, Shintaro Maeda, Yuhei Kamada, N. Kuwabara, (unknown), Tatsuya Nakatani	30
19	Association between chronic kidney disease and small residual urine volumes in patients with benign prostatic hyperplasia 2010 ·Nephrology ·Takeshi Yamasaki, Toshihide Naganuma, Taro Iguchi, Yoshikazu Kuroki, Nobuyuki Kuwabara, Yoshiaki Takemoto, Tetsuo Shoji, Tatsuya Nakatani	14
20	Association of Prostate Cancer and Manganese Superoxide Dismutase AA Genotype Influenced by Presence of Occult Cancer in Control Group 2008 ·Urology ·Taro Iguchi, Ching Y. Wang, Nicolas Barry Delongchamps, (unknown), Tatsuya Nakatani, Gustavo de la Roza, Gabriel P. Haas	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact